A Colony-Forming Assay for Experimental Tumours Using the Plasma Clot Diffusion Chamber

  • S. Öhl
  • S. Seeber
  • W. R. Boecker
  • C. G. Schmidt
Conference paper


A direct tumor-colony assay in vivo was developed to measure population renewal and colonizing property as well as sensitivity of tumor stem cells to anti-cancer drugs. Ehrlich ascites tumor (EAT) cells with acquired resistance to daunomycin (DNM) have been cloned in plasma clot diffusion chambers (PCDC). Cultures were implanted into the peritoneal cavity of preirradiated mice under standard culture conditions to investigate colony growth and single cell recovery after treatment with proteolytic enzymes. The number of tumor colonies was proportional to the number of cells plated between concentrations of 0.5 x 103 to 5 x 103 cells/PCDC in resistant and non-resistant cell lines, whereas the plating efficiency appeared to be significantly lower in the resistant populations. The clones responded differently to the cytotoxic effects of DNM, with a good correlation with optimal dose schedule. This assay sufficiently warrants large scale testing of new agents to estimate the absolute number or percent of viable cancer cells after treatment.


Tumor Coloni Population Doubling Time Tumor Stem Cell Ehrlich Ascites Tumor Cell Diffusion Chamber 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Algire, G.H., Weaver, J.M., Prehn, R.T.: Growth of cells in vivo in diffusion chambers. I. Survival of homografts in immunized mice. J. Natl. Cancer Inst. 15, 493–508 (1954)PubMedGoogle Scholar
  2. 2.
    Amos, D.B., Wakefield, J.D.: Growth of mouse ascites tumor cells in diffusion chambers. II. Lysis and growth inhibition by diffusible isoantibody. J. Natl. Cancer Inst. 22, 1077–1092 (1959)PubMedGoogle Scholar
  3. 3.
    Benestad, H.: Formation of granulocytes and macrophages in diffusion chamber cultures of mouse blood leucocytes. Scand. J. Haematol. 7, 279–288 (1970)PubMedCrossRefGoogle Scholar
  4. 4.
    Cain, B.F., Calveley, S.B., Boreham, B.A., West, C., Price, N.A., Walker, D.J., Churchouse, M.J.: Drug-tumor sensitivity matching procedure using diffusion chambers in vivo. Cancer Treat. Rep. 58, 189–205 (1974)Google Scholar
  5. 5.
    Danø, K.: Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells. Biochim. Biophys. Acta 323, 466–483 (1973)PubMedCrossRefGoogle Scholar
  6. 6.
    Danø, K., Frederiksen, S., Hellung-Larsen, P.: Inhibition of DNA and RNA synthesis by daunorubicin in sensitive and resistant Ehrlich ascites tumor cells in vitro. Cancer Res. 32, 1307–1314 (1972)PubMedGoogle Scholar
  7. 7.
    Edwards, J.L., Koch, A.L., Youcis, P., Freese, H.L., Laite, M.B., Donalson, J.T.: Some characteristics of DNA synthesis and the mitotic cycle in Ehrlich ascites tumor cells. J. Biophys. Biochem. Cytol. 7, 273–281 (1960)PubMedCrossRefGoogle Scholar
  8. 8.
    Evgenjeva, T.P.: Heterotransplantation of human cancers to animals by means of diffusion chambers. Eur. J. Cancer 6, 533–535 (1970)PubMedGoogle Scholar
  9. 9.
    Gabourel, J.D., Fox, K.E.: Cell culture in vivo. I. Growth of L-fibroblast and sarcoma 180 cell lines in diffusion chambers in vivo. Cancer Res. 19, 1210–1216 (1959)PubMedGoogle Scholar
  10. 10.
    Gerard, E., Carsten, A.L., Cronkite, E.P.: The proliferative potential of plasma clot erythroid colony-forming cells in diffusion chambers. Blood Cells 4, 105–128 (1978)PubMedGoogle Scholar
  11. 11.
    Heckmann, U.: Neue Möglichkeiten einer Resistenzprüfung menschlicher Karzinomgewebe gegen Zytostatika im In-vivo-Test. Dtsch. Med. Wochenschr. 92, 932–935 (1967)PubMedCrossRefGoogle Scholar
  12. 12.
    Keeb, G., Lala, P.K.: Effects of Ehrlich ascites tumor transplantation in mice on the distribution of cells capable of forming hemopoietic colonies in vitro. Eur. J. Cancer 14, 331–342 (1978)PubMedGoogle Scholar
  13. 13.
    Laerum, O.D., Grüneisen, A., Rajewsky, M.F.: Proliferative properties of malignant cell populations cultured in intraperitoneal diffusion chambers. Eur. J. Cancer 9, 533–541 (1973)PubMedGoogle Scholar
  14. 14.
    Lala, P.K.: Influence of local environment on the growth parameters of the Ehrlich ascites tumor. Eur. J. Cancer 8, 197–204 (1972)PubMedGoogle Scholar
  15. 15.
    Meek, R.A., Carsten, A.L., Kelsch, J.J.: Growth of HeLa cells in diffusion chamber cultures in vivo. Cancer Res. 36, 2317–2320 (1976)Google Scholar
  16. 16.
    Powell, A.K.: The cultivation in vitro of mouse ascites tumour cells. The effects of explants of solid tissues upon the growth of the tumour cells. Br. J. Cancer 11, 570–589 (1957)PubMedCrossRefGoogle Scholar
  17. 17.
    Riehm, H., Biedler, J.L.: Cellular resistance to daunomycin in Chinese hamster cells in vitro. Cancer Res. 31, 409–412 (1971)PubMedGoogle Scholar
  18. 18.
    Roper, P.R., Drewinko, B.: Comparison of in vitro methods to determine drug-induced cell lethality. Cancer Res. 36, 2182–2188 (1976)PubMedGoogle Scholar
  19. 19.
    Seeber, S., Meshkov, T., Schmidt, C.G.: Tween 80 restores adriamycin antitumor efficacy in adriamycin-resistant Ehrlich ascites tumor in vitro and in vivo. In: Current chemotherapy. Proceedings of the 10th International Congress of Chemotherapy, Zurich, Switzerland, September, 1977. Siegenthaler, W., Luthy, R. (eds.), pp. 1249–1250. Washington, D.C: American Society for Microbiology 1978Google Scholar
  20. 20.
    Skipper, H.E., Schabel, F.M. Jr., Wilcox, W.S.: Experimental evaluation of potential anticancer agents. XIV. Further study of certain basic concepts underlying chemotherapy of leukemia. Cancer Chemother. Rep. 45, 5–28 (1965)PubMedGoogle Scholar
  21. 21.
    Skovsgaard, T.: Transport and binding of daunorubicin, adriamycin and rubidazone in Ehrlich ascites tumour cells. Biochem. Pharmacol. 26, 215–222 (1977)PubMedCrossRefGoogle Scholar
  22. 22.
    Steinberg, H.N., Handler, E.S., Handler, E.E.: Assessment of erythrocytic and granulocytic colony formation in an in vivo plasma clot diffusion chamber system. Blood 47, 1041–1051 (1976)PubMedGoogle Scholar
  23. 23.
    Straube, R.L.: Fluid accumulation during initial stages of ascites tumor growth. Cancer Res. 18, 51–65 (1958)Google Scholar
  24. 24.
    Teichmann, B., Wittig, G.: Untersuchungen über das Wachstum von Tumorzellen in Diffusionskammern. Z. Naturforsch. [B] 19, 54–60 (1964)Google Scholar
  25. 25.
    Wilcox, W.S., Griswold, D.P., Laster, W.R. Jr., Schabel, F.M. Jr., Skipper, H.E.: Experimental evaluation of potential anticancer agents. XVII. Kinetics of growth and regression after treatment of certain solid tumors. Cancer Chemother. Rep. 47, 27–39 (1965)PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1980

Authors and Affiliations

  • S. Öhl
  • S. Seeber
  • W. R. Boecker
  • C. G. Schmidt

There are no affiliations available

Personalised recommendations